Motley Fool Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-155,388
Closed -$6.19M 131
2024
Q4
$6.19M Sell
155,388
-31,583
-17% -$1.51M 0.32% 95
2024
Q3
$12.5M Sell
186,971
-8,964
-5% -$823K 0.63% 58
2024
Q2
$23.2M Sell
195,935
-4,111
-2% -$520K 1.18% 19
2024
Q1
$21.3M Buy
+200,046
New +$20.2M 1.1% 24

Other funds holding MRNA

Motley Fool Wealth Management's MRNA Position: Q1 2025 in Review

Motley Fool Wealth Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 155,388 shares — an estimated $6.19M sold.

Motley Fool Wealth Management first reported a position in MRNA in Q1 2024 and held it in 4 quarters. The position peaked at $23.2M in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Motley Fool Wealth Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Motley Fool Wealth Management sold 155,388 Moderna shares in Q1 2025, an estimated $6.19M.
  • Motley Fool Wealth Management first reported a position in Moderna in Q1 2024 and held it in 4 quarters.
  • Motley Fool Wealth Management's Moderna position peaked at $23.2M in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Motley Fool Wealth Management's 13F filing for Q1 2025, filed 12 May 2025.